New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies.

scientific article published in February 2007

New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4049/JIMMUNOL.178.4.2476
P698PubMed publication ID17277155
P5875ResearchGate publication ID6527915

P2093author name stringPhilippe J Sansonetti
Toshihiko Suzuki
Mi-Na Kweon
Doo-Hee Shim
Sung-Moo Park
Sun-Young Chang
Chihiro Sasakawa
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectshigellosisQ327298
P304page(s)2476-2482
P577publication date2007-02-01
P1433published inJournal of ImmunologyQ3521441
P1476titleNew animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies.
P478volume178

Reverse relations

cites work (P2860)
Q24338298A bacterial effector targets Mad2L2, an APC inhibitor, to modulate host cell cycling
Q33676706A challenge model for Shigella dysenteriae 1 in cynomolgus monkeys (Macaca fascicularis).
Q64996406A murine model of diarrhea, growth impairment and metabolic disturbances with Shigella flexneri infection and the role of zinc deficiency.
Q37709067A new paradigm of bacteria-gut interplay brought through the study of Shigella
Q33678906A piglet model of acute gastroenteritis induced by Shigella dysenteriae Type 1
Q92822336An Oral Inoculation Infant Rabbit Model for Shigella Infection
Q35049447Autophagy controls an intrinsic host defense to bacteria by promoting epithelial cell survival: a murine model
Q45986472Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment.
Q35796146Bioimage analysis of Shigella infection reveals targeting of colonic crypts
Q33535907Caspase-1 activation via Rho GTPases: a common theme in mucosal infections?
Q26749369Cellular Aspects of Shigella Pathogenesis: Focus on the Manipulation of Host Cell Processes
Q33416439Characterisation of early mucosal and neuronal lesions following Shigella flexneri infection in human colon
Q63976613Critical role of bacterial dissemination in an infant rabbit model of bacillary dysentery
Q37713347Development of an Aotus nancymaae model for Shigella Vaccine immunogenicity and efficacy studies
Q37458618Effect of wild-type Shigella species and attenuated Shigella vaccine candidates on small intestinal barrier function, antigen trafficking, and cytokine release
Q60584774Enterobacteria and host resistance to infection
Q64055283Evaluating Shigella flexneri Pathogenesis in the Human Enteroid Model
Q37638547Evaluation of an intragastric challenge model for Shigella dysenteriae 1 in rhesus monkeys (Macaca mulatta) for the pre-clinical assessment of Shigella vaccine formulations
Q35498376HPV16L1-attenuated Shigella recombinant vaccine induced strong vaginal and systemic immune responses in guinea pig model
Q57097990Hemagglutinating activity is directly correlated with colonization ability of shigellae in suckling mouse model
Q64067571How Viral and Intracellular Bacterial Pathogens Reprogram the Metabolism of Host Cells to Allow Their Intracellular Replication
Q88954037Human Enteric α-Defensin 5 Promotes Shigella Infection by Enhancing Bacterial Adhesion and Invasion
Q51975208Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
Q28537818Impact of dynasore an inhibitor of dynamin II on Shigella flexneri infection
Q26750857Implications of Spatiotemporal Regulation of Shigella flexneri Type Three Secretion Activity on Effector Functions: Think Globally, Act Locally
Q50176712Improving chances for successful clinical outcomes with better preclinical models
Q50039350Live non-invasive Shigella dysenteriae 1 strain induces homologous protective immunity in a guinea pig colitis model.
Q90442263Mapping of Shigella flexneri's tissue distribution and type III secretion apparatus activity during infection of the large intestine of guinea pigs
Q90385992Mechanisms of bacillary dysentery: lessons learnt from infant rabbits
Q100731064NAIP-NLRC4-deficient mice are susceptible to shigellosis
Q33783871Pathogenicity of Shigella in chickens
Q37105553Progress and pitfalls in Shigella vaccine research
Q46677252Protective immunity by oral immunization with heat-killed Shigella strains in a guinea pig colitis model
Q33618994Shigella flexneri Inhibits Intestinal Inflammation by Modulation of Host Sphingosine-1-Phosphate in Mice
Q34806959Shigella flexneri targets the HP1γ subcode through the phosphothreonine lyase OspF
Q35221181Shigella outer membrane protein PSSP-1 is broadly protective against Shigella infection
Q92823992Shigella promotes major alteration of gut epithelial physiology and tissue invasion by shutting off host intracellular transport
Q92968788Shigella-mediated immunosuppression in the human gut: subversion extends from innate to adaptive immune responses
Q27687005Shigella: a model of virulence regulation in vivo
Q34518265Status of vaccine research and development for Shigella
Q27333637The zebrafish as a new model for the in vivo study of Shigella flexneri interaction with phagocytes and bacterial autophagy
Q46354821Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: a new combination of gene deletions for 2nd generation live attenuated vaccine candidates
Q52625300Use of zebrafish to study Shigella infection.
Q33578045Vaccines against human diarrheal pathogens: current status and perspectives

Search more.